FDA Sends Warning Letters to Multiple Companies for Illegally Marketing CBD Products

Representatives of the US Food and Drug Administration issued warning letters on Monday to multiple companies for marketing CBD-specific products in ways that violate federal law. The agency issued warning letters to 15 commercial entities. Seven additional companies received similar letters earlier this year. The FDA alleges that the companies marketed CBD as either a dietary supplement or as a food additive, or in a manner that implied it could prevent or cure serious disease –- all of which violate the federal Food, Drug & Cosmetics Act. Following the passage of the 2018 Farm Bill, which removed low-THC hemp and extracts from the plant from the Controlled Substances Act, the agency advised: “Cannabis and cannabis-derived products claiming in their marketing and promotional materials that they’re intended for use in the diagnosis, cure, mitigation, treatment, or prevention of diseases are considered new drugs or new animal drugs and must go through the FDA drug approval process for human or animal use before they are marketed in the U.S. … Additionally, it’s unlawful under the FD&C Act to introduce food containing added CBD or THC into interstate commerce, or to market CBD or THC products as, or in, dietary supplements, regardless of…

Excerpt only …
READ MORE BELOW
Source : norml
Link to original : FDA Sends Warning Letters to Multiple Companies for Illegally Marketing CBD Products
reposted by Cannabis News World